Zynerba Pharmaceuticals

-$0.09 (-1.94%) As of 6:10 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZYNE and other ETFs, options, and stocks.

About ZYNE

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions.

CEO

Armando Anido

Employees

Headquarters

Devon, Pennsylvania

Founded

2007

ZYNE Key Statistics

Market Cap

219.69M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

509.43K

High Today

$4.65

Low Today

$4.51

Open Price

$4.63

Volume

299.67K

52 Week High

$9.00

52 Week Low

$3.15

Analyst Ratings

71%

of 7 ratings

Buy

71.4%

Hold

28.6%

Sell

ZYNE Earnings

-$0.78

-$0.52

-$0.26

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 10, Pre-Market